UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical microbiology and infection, ISSN 1198-743X, 07/2014, Volume 20, Issue 7, pp. 698 - 705
Breakpoint | European Committee on Antimicrobial Susceptibility Testing | species | Candida | candidaemia | Clinical and Laboratory Standards Institute | resistance | Resistance | Candidaemia | Clinical and laboratory standards institute | European committee on antimicrobial susceptibility testing | Species | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Candidemia - microbiology | Fluconazole - pharmacology | Prospective Studies | Voriconazole - pharmacology | Candidemia - epidemiology | Candida - isolation & purification | Microbial Sensitivity Tests | Candida - classification | Switzerland - epidemiology | Candida - drug effects | Drug Resistance, Fungal | Lipopeptides | Echinocandins - pharmacology | Surveys | Mycoses | Fluconazole | Health aspects | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 04/2014, Volume 20, Issue 4, pp. O255 - O266
Antimicrobial susceptibility testing | Mueller–Hinton agar | disk diffusion | European Committee on Antimicrobial Susceptibility Testing | zone diameter breakpoints | MIC | Disk diffusion | European committee on antimicrobial susceptibility testing | Zone diameter breakpoints | Mueller-Hinton agar | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Bacteria - isolation & purification | Microbial Sensitivity Tests - standards | Europe | Humans | Bacteria - drug effects | Anti-Bacterial Agents - pharmacology | Bacterial Infections - diagnosis | Microbial Sensitivity Tests - methods | Laboratories | Analysis | Methods | Index Medicus
Journal Article
Journal of laboratory physicians, ISSN 0974-2727, 07/2018, Volume 10, Issue 3, pp. 289 - 293
Original Article | Urinary tract infections | Antibiotics | Health aspects | Standards | Urine | Laboratories | Antimicrobial agents | Drug resistance | Epidemiology | Accuracy | E coli | Surveillance | Agreements | Urogenital system | Carbapenem | European Committee on antimicrobial susceptibility testing | Clinical and Laboratory Standards Institute | interpretation | Original | european committee on antimicrobial susceptibility testing | clinical and laboratory standards institute | carbapenem
Journal Article
Annals of clinical microbiology and antimicrobials, ISSN 1476-0711, 04/2016, Volume 15, Issue 1, pp. 21 - 21
Clinical Laboratory Standards Institute (CLSI) | European Committee on Antimicrobial Susceptibility Testing (EUCAST) | Minimum inhibitory concentrations (MIC) | Antimicrobial susceptibility testing (AST) | Life Sciences & Biomedicine | Microbiology | Science & Technology | Laboratories, Hospital - organization & administration | Microbial Sensitivity Tests - standards | Cross-Sectional Studies | Escherichia coli - drug effects | Humans | Hospitals, Teaching | Anti-Bacterial Agents - pharmacology | Pseudomonas aeruginosa - drug effects | Kenya | Staphylococcus aureus - drug effects | Microbial Sensitivity Tests - methods | Laboratories, Hospital - standards | Antibiotics | Comparative analysis | Medical laboratories | Analysis | Standards | Antimicrobial agents | Index Medicus
Journal Article
Journal of clinical periodontology, ISSN 0303-6979, 08/2019, Volume 46, Issue 8, pp. 846 - 854
agar dilution method | β‐lactams | breakpoints | antimicrobial resistance | European Committee of Antimicrobial Susceptibility Testing | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Microbial Sensitivity Tests | Aggregatibacter actinomycetemcomitans | Anti-Bacterial Agents | Anti-Infective Agents | Amoxicillin | Polymerase chain reaction | Antimicrobial agents | Carbon dioxide | Minimum inhibitory concentration | Index Medicus | Dentistry
Journal Article
BMC infectious diseases, ISSN 1471-2334, 03/2019, Volume 19, Issue 1, pp. 281 - 281
Euro-GASP | European Union (EU) | Gonorrhoea | European economic area (EEA) | EUCAST | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Disk Diffusion Antimicrobial Tests - standards | Reproducibility of Results | Microbial Sensitivity Tests - standards | Neisseria gonorrhoeae - drug effects | Laboratories | Europe | Drug Resistance, Bacterial | Anti-Bacterial Agents - pharmacology | Quality Control | Neisseria gonorrhoeae | Research | Analysis | Quality control | Performance evaluation | Breakpoints | Phenotypes | Curricula | Antimicrobial agents | Gonorrhea | Drug resistance | Antiinfectives and antibacterials | Quality assurance | Testing laboratories | Surveillance | Minimum inhibitory concentration | Diagnostic systems | Antimicrobial resistance | Quality assessment | Condoms | Public health | Index Medicus
Journal Article
FEMS yeast research, ISSN 1567-1356, 12/2012, Volume 12, Issue 8, pp. 890 - 896
Clinical and Laboratory Standards Institute (CLSI) | candidemia agents | antifungal drugs | EUCAST | European Committee of Susceptibility Testing | Candidemia agents | Antifungal drugs | Life Sciences & Biomedicine | Microbiology | Biotechnology & Applied Microbiology | Mycology | Science & Technology | Antifungal Agents - pharmacology | Candidemia - microbiology | Fluconazole - pharmacology | Pichia - isolation & purification | Pichia - drug effects | Tertiary Care Centers | DNA, Fungal - genetics | Drug Resistance, Fungal - drug effects | Humans | Amphotericin B - pharmacology | Blood - microbiology | Pyrimidines - pharmacology | Candida - isolation & purification | Itraconazole - pharmacology | Triazoles - pharmacology | Candida - classification | Candidemia - drug therapy | Voriconazole | Brazil | Candida - drug effects | Pichia - classification | Microbial Sensitivity Tests - methods | Hospitals | Fluconazole | Amphotericin B | Medical laboratories | Cross-resistance | Candidemia | Drug resistance | Itraconazole | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 07/2012, Volume 67, Issue 7, pp. 1569 - 1577
CLSI | Clinical Laboratory Standards Institute | CTX-M β-lactamases | EUCAST | European Committee on Antimicrobial Susceptibility Testing | KPC β-lactamases | Ceftazidime | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Bacteria - isolation & purification | Animals | beta-Lactamases - genetics | beta-Lactamases - analysis | Humans | Bacteria - drug effects | Bacteria - enzymology | Microbial Sensitivity Tests - methods | Bacterial Infections - microbiology | Prescription drugs | Enzymes | Epidemiology | Disease control | Index Medicus | Drugs | Breakpoints | Pharmacodynamics | Cefepime | Data processing | carbapenemase | Infection | beta -Lactamase | Cephalosporins | Minimum inhibitory concentration | Carbapenems
Journal Article
Indian journal of medical microbiology, ISSN 0255-0857, 01/2020, Volume 38, Issue 1, pp. 58 - 65
Gram-negative bacilli | susceptibility testing | Clinical and Laboratory Standards Institute | European Committee on Antimicrobial Susceptibility Testing | colistin | Broth microdilution | Colistin | Comparative analysis | Standards | Methods | Drug resistance in microorganisms | Testing | european committee on antimicrobial susceptibility testing | clinical and laboratory standards institute | gram-negative bacilli | broth microdilution
Journal Article
Revue scientifique et technique (International Office of Epizootics), ISSN 0253-1933, 2012, Volume 31, Issue 1, pp. 33 - 41
Resistance | Breakpoint | Clinical breakpoint | European Committee on Antimicrobial Susceptibility Testing | Harmonisation | Epidemiological cut-off value | Susceptibility testing | Clinical and Laboratory Standards Institute | Wild type | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Guidelines as Topic | Anti-Infective Agents - pharmacology | Humans | Bacteria - drug effects | Drug Resistance, Bacterial | Dose-Response Relationship, Drug | Host-Pathogen Interactions | Reference Standards | Animals | Anti-Infective Agents - administration & dosage | Microbial Sensitivity Tests - standards | Anti-Infective Agents - pharmacokinetics | Microbial Sensitivity Tests - methods
Journal Article
Indian journal of medical microbiology, ISSN 0255-0857, 01/2019, Volume 37, Issue 1, pp. 91 - 94
Acinetobacter baumannii | European Committee on Antimicrobial Susceptibility Testing | interpretation | tigecycline | Klebsiella pneumoniae | Life Sciences & Biomedicine | Immunology | Science & Technology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Klebsiella pneumoniae - drug effects | Humans | Klebsiella pneumoniae - genetics | Gram-Negative Bacterial Infections - drug therapy | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - genetics | Drug Resistance, Multiple, Bacterial - genetics | Tigecycline - pharmacology | Pneumonia | Bacterial pneumonia | Klebsiella | Breakpoints | Regulatory agencies | Automation | Test procedures | Infections | Pharmacology | Drug resistance | Antiinfectives and antibacterials | Antibiotics | E coli | Surveillance | Gram-negative bacteria | Tigecycline | Drug dosages
Journal Article
Mediterranean journal of infection, microbes & antimicrobials, ISSN 2147-673X, 12/2019, Volume 8
Journal Article
13.
Full Text
Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study
Clinical microbiology and infection, ISSN 1198-743X, 12/2006, Volume 12, Issue 12, pp. 1185 - 1192